Association for Molecular Pathology
A medical subspecialty professional society
Based in MD
AI Overview
With $1.5M in lobbying spend across 30 quarterly filings, Association for Molecular Pathology is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2019 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $150K |
| 2020 | $150K |
| 2021 | $168K |
| 2022 | $252K |
| 2023 | $210K |
| 2024 | $282K |
| 2025 | $282K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Association for Molecular Pathology disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Health Issues, Medicare/Medicaid, Copyright/Patent, Consumer Issues and 1 more
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Coverage and reimbursement for molecular diagnostics
Medicare coverage of next generation sequencing based tests for cancer
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
No bill #, reform Sec. 101 of the Patent Act
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.